Results 221 to 230 of about 1,994,101 (341)
Temporal Lobe Epilepsy With GAD Antibodies-Time to Give Up, or Time to Double Down? [PDF]
Steriade C.
europepmc +1 more source
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi +6 more
wiley +1 more source
Differential glymphatic dysfunction and memory correlation in temporal lobe epilepsy subtypes. [PDF]
Chen R +19 more
europepmc +1 more source
Exploring the role of apolipoprotein ε4 in progressive myoclonic epilepsy type 1
Abstract Objective Progressive myoclonic epilepsy type 1 (EPM1) is a neurodegenerative disease caused by biallelic variants in the cystatin B (CSTB) gene. Despite a progressive course, phenotype severity varies among patients, even within families. We studied the potential role of APOE ε4 in modifying phenotypic diversity in EPM1, given its established
Janina Gunnar +10 more
wiley +1 more source
Twins with temporal lobe epilepsy: genetic contributions to hippocampal sclerosis and other subtypes. [PDF]
Dang YL +6 more
europepmc +1 more source
Abstract Objective Neurocysticercosis (NCC) is a common parasitic infection of the central nervous system and a known cause of focal epilepsy. Its potential role in triggering or contributing to mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE‐HS) is suggested, but the impact on brain volumetry remains unclear.
Jaisa Quedi Araújo +10 more
wiley +1 more source
Glucocorticoid-Induced Tumor Necrosis Factor Receptor Ligand: Correlation and Therapeutic Potential for Cognitive Impairment in Temporal Lobe Epilepsy. [PDF]
Li M, Shi J, Pan X, Huang H.
europepmc +1 more source

